A cross-country qualitative analysis of teachers' perceptions of asthma care in sub-Saharan Africa
- PMID: 37741822
- PMCID: PMC10517916
- DOI: 10.1038/s41533-023-00354-7
A cross-country qualitative analysis of teachers' perceptions of asthma care in sub-Saharan Africa
Abstract
Asthma is the most common chronic respiratory disease among school-going adolescents worldwide. However, the burden of severe asthma is highest in Sub-Saharan Africa. This study aimed to explore teachers' perceptions of asthma care across six African countries. We conducted focus group discussions (FGDs) using a semi-structured interview guide. Interviews were audio-recorded, transcribed verbatim and analysed thematically. FGDs were conducted in Kumasi(Ghana), Blantyre (Malawi), Lagos (Nigeria), Durban (South Africa), Kampala (Uganda), and Harare (Zimbabwe) between 01 November 2020 and 30 June 2021. We identified two key themes related to asthma care; barriers to asthma care and suggestions to improve the care of adolescents with asthma. Barriers reported by teachers included a lack of knowledge and skills among themselves, adolescents, and caregivers. In addition, some traditional beliefs of teachers on asthma exacerbated challenges with asthma care in schools. Regarding suggestions, most teachers identified a need for all-inclusive asthma training programmes for teachers, adolescents and caregivers, focusing on acute episodes and mitigating triggers. Utilising teachers with personal experiences with asthma to advocate and support these initiatives was suggested. Further suggestions included the need for annual screening to enable early identification of adolescents with asthma and clarify restrictions on teachers administering asthma medications. Teachers across African schools identify multiple barriers to asthma care. Structured school education programs and annual asthma screening are key to addressing some barriers to care.
© 2023. Springer Nature Limited.
Conflict of interest statement
The author(s) declare that they have no financial or personal relationship(s) that may have inappropriately influenced them in writing this article. The funder did not influence the results and compiling of the manuscript. J.G. reports personal fees from GSK, personal fees from Vifor Pharmaceuticals, personal fees from Novartis, personal fees from BV Pharma, and personal fees from AstraZeneca outside the submitted work. R.M. reports consultancy and advisory board membership from AstraZeneca, Boehringer, and Organon.
Figures
References
-
- World Health Organization. The Global Asthma Report. http://globalasthmareport.org/resources/Global_Asthma_Report_2022.pdf (2022).
-
- Lai, C. K., et al. International Study of Asthma and Allergies in Childhood Phase Three Study FGD. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax,64, 476–483 (2009). - PubMed